A new clinical trial report finds that stereotactic radiation therapy offers long-term survival outcomes comparable to surgery for patients with small, early-stage non-small cell lung cancer (NSCLC).

In this episode of the Treating Together podcast, Edward S. Kim, MD, MBA, and Neel Shah, MD, discuss the rapid advancements in lung cancer therapy, the challenges community physicians face in staying ...

Radiation therapy could be an underused tool to reduce pelvic relapse risk for patients with locally advanced, ...

Lung cancer remains one of the deadliest cancers worldwide, with survival rates stubbornly low despite advances in surgery, chemotherapy, and immunotherapy. But a new discovery may change the way ...

The robotic surgery market is undergoing rapid transformation, driven by technological advancements, increasing adoption in ...

Cleveland Clinic delivers care from prevention to rehab, minimally invasive to complex A growing destination for medical ...